跳至主要内容
临床试验/CTRI/2024/07/071199
CTRI/2024/07/071199已完成不适用

A cross sectional, non-randomized clinical performance study to collect the data using Vivaray Hb pro and use the device generated hemoglobin value for validation by comparing it with the hemoglobin value generated from the gold standard (calibrated blood cell counter).

Bosch Global Software Technologies Pvt. Ltd.4 个研究点 分布在 1 个国家目标入组 763 人开始时间: 2024年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
763
试验地点
4
主要终点
The objective of the study is to validate the clinical performance of Vivaray Hb pro

研究概览

简要总结

The World Health Organization classifies anemia as decrease in the number red blood cells or insufficient oxygen carrying capacity to meet the physiological needs, which varies by age, sex, altitude, smoking and pregnancy status.

Deficiency in folate, vitamin-B12, vitamin-A, chronic inflammations, ulcers, pregnancy, parasitic infections, hemoglobinopathies, etc. can all lead to anemia, but iron-deficiency anemia is considered to be one of the leading causes of anemia in the world.

It is advisable for hemoglobin (Hb) values to be continuously measured among people who undergo hemodialysis or suspected with anemia and oligocythemia (Kavsaoglu, Polat, & Hariharan, 2015).

The purpose of this study tovalidate the clinical performance of Vivaray Hb pro and use the device generated hemoglobin value for validation by comparing it with the hemoglobin value generated from the gold standard (calibrated blood cell counter).

研究设计

研究类型
Observational

入排标准

年龄范围
9.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Male or Female patients with age of greater than eight (8) years
  • Range of Hemoglobin 4-18 g/dl.
  • Able to give written informed consent, assent or parents’ consent form.
  • Finger size: 8 mm to 23 mm (The device is designed to fit fingers in this range) and index finger preferred to capture the signal.

排除标准

  • Patients with paronychia, fungal infections of the nail bed, blistering disorders involving the fingers, hyper-keratosis, nail polish, mehendi and callus formation on nail.

结局指标

主要结局

The objective of the study is to validate the clinical performance of Vivaray Hb pro

时间窗: Enrolment and Study Completion Visit – Visit 1

and use the device generated hemoglobin value for validation by comparing it with the hemoglobin value generated from the gold standard (calibrated blood cell counter).

时间窗: Enrolment and Study Completion Visit – Visit 1

次要结局

  • NA(NA)

研究者

发起方
Bosch Global Software Technologies Pvt. Ltd.
申办方类型
Other [Engineering Company]
责任方
Principal Investigator
主要研究者

Dr Dipti Gupta

Dr. Diptis Multispecialty Clinics

研究点 (4)

Loading locations...

相似试验